The landscape of dementia prognosis has developed considerably with the arrival of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that may detect Alzheimer's pathology many years before indications arise. Whilst these technological advances stand for amazing progress in knowing neurodegenerative illnesses, they have not diminished https://nikitaf219jvg1.bloggip.com/profile